Skip to main content
Premium Trial:

Request an Annual Quote

NIH Plans Genetic Testing Registry

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institutes of Health is starting a public database on genetic testing that will allow consumers, researchers, health care providers, and others search through information submitted by genetic test providers, NIH said today.

The Genetic Testing Registry will serve as a resource of information about the availability, validity, and utility of the more than 1,600 genetic tests currently on the market. The goal of the GTR project is to use that information to advance both public health and research.

The program will encourage test providers to enhance transparency by sharing information about their tests with the public, will provide a resource for patients and scientists to find labs that offer particular tests, and will facilitate genomic data sharing, NIH said. Genetic test data will be integrated with information from other genetic, scientific, and medical databases in order to facilitate new research.

"The need for this database reflects how far we have come in the last 10 years," NIH Director Francis Collins said in a statement. "The registry will help consumers and health care providers determine the best options for genetic testing, which is becoming more and more common and accessible."

The GTR, which is expected to be available in 2011, will be overseen by NIH's Office of the Director, and its development will be handled by the National Center for Biotechnology Information.

While NIH is developing the site, it said that it will engage with a range of stakeholders, including genetic test developers, test kit makers, health care providers, patients, and researchers, for the best ways to collect and display test information.

The Food and Drug Administration and the Centers for Medicare and Medicaid Services also will provide consulting to the project.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.